Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4997849 | PMC |
| http://dx.doi.org/10.1128/AAC.00388-16 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
chronic infections in patients with bronchiectasis: a silent reservoir of carbapenemase-producing epidemic high-risk clones.
JAC Antimicrob Resist
April 2025
Servicio de Microbiología, Hospital Univeristario Son Espases, Instituto de Investigación Sanitaria Illes Balears, CIBERINFEC, Palma de Mallorca, Spain.
Objectives: is one of the major drivers of morbidity and mortality in patients with chronic underlying diseases. Whereas cystic fibrosis (CF) strains have been well studied, non-CF bronchiectasis isolates have received less scientific attention.
Methods: We determined the antibiotic susceptibility profiles of a collection of 100 isolates recovered from a total of 100 non-CF bronchiectasis patients attending a Catalonian hospital.
First VIM-producing representative of group from the largest Bulgarian hospital.
Folia Med (Plovdiv)
December 2024
Medical University of Plovdiv, Plovdiv, Bulgaria.
Here we describe the first detected VIM-2-producing representative of Pseudomonasputida group - Pseudomonaskurunegalensis from the largest Bulgarian hospital - St George University Hospital in Plovdiv.
View Article and Find Full Text PDFPBP-3 directed therapy in VIM-producing Pseudomonas aeruginosa creates bacterial transformers, persisters in disguise.
Int J Antimicrob Agents
September 2024
Division of Clinical and Translational Therapeutics, Department of Pharmacy Practice, School of Pharmacy and Pharmaceutical Sciences, University at Buffalo, Buffalo, New York, USA. Electronic address:
Objectives: The proliferation of metallo-β-lactamase (MBL)-producing Pseudomonas aeruginosa represents a significant public health threat. P. aeruginosa undergoes significant phenotypic changes that drastically impair antibiotic efficacy.
View Article and Find Full Text PDFHospital wastewater as source of human pathogenic bacteria: A phenotypic and genomic analysis of international high-risk clone VIM-2-producing Pseudomonas aeruginosa ST235/O11.
Environ Res
August 2024
Laboratory of Ecotoxicology and Environmental Parasitology, Ribeirão Preto College of Nursing, University of São Paulo, Brazil.
Pseudomonas aeruginosa belong to the special pathogen group capable of causing serious infections, with high mortality rates. The aim of this study was to describe the antibiotic resistance and genomic characteristics of Pseudomonas aeruginosa belonging to international high-risk clone ST235 (GPAE0131 isolate), obtained from hospital wastewater. P.
View Article and Find Full Text PDFCTX-M-15/27-positive Escherichia coli and VIM-2-producing Pseudomonas putida in free-living pigeons (Columba livia) in Tunisia.
J Glob Antimicrob Resist
March 2024
Faculté de Médecine Ibn Al Jazzar Sousse, Laboratoire de Recherche Biophysique Métabolique et Pharmacologie Appliquée, Université de Sousse, Sousse, Tunisia.
Objectives: Wild birds are vectors of antimicrobial resistance. Birds living in close contact with humans or other animals, like feral pigeons (Columba livia), might be especially prone to acquire resistance genes such as those encoding extended-spectrum beta-lactamases (ESBLs) and carbapenemases.
Methods: Cloacal samples (n = 206) of free-living feral pigeons (C.